This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Frank Stein and Paul S. May: Devoted to Helping Families Thrive, Supporting People with Low Vision and Finding a Cure for Glaucoma

Frank and Paul strongly believe that research will ultimately lead to a cure for glaucoma.

Allergan Receives FDA Approval for XEN Glaucoma Treatment System

On November 22, 2016, Allergan announced that the U.S. Food and Drug Administration (FDA) has cleared the XEN® Glaucoma Treatment System for use in the United States.

New Contact Lens Technology Could Change the Lives of Glaucoma Patients

New contact lens technologies could make it easier for patients to comply with their medication plans and monitor both the progress of the disease and the efficacy of newly prescribed drugs.

Curing Glaucoma-related Vision Loss with High-contrast Visual Stimulation

A research study has found that high-contrast visual activity promotes optic nerve regrowth.

Research into Nerve Growth Factor for Glaucoma Offers New Hope for Treatment

Nerve regeneration focuses on ways to regrow nerves. Neuroprotection is preventing the death of nerve cells. Both goals must be developed before vision loss due to glaucoma can be stopped or reversed.

Chris Wilmoth and the Power of Family in Fighting Glaucoma

“Glaucoma Research Foundation is the best out there. They are ahead of the curve—they’re looking forward for the cure.” — Cathy Wilmoth

Saving Sight in Glaucoma: Why the Brain May Hold the Key

What causes vision loss in glaucoma? First is elevated ocular pressure, and second is damage to the optic nerve, which is the structure that sends visual information to the brain.

New Research Holds Promise For Restoring Lost Vision

Stanford researchers, funded in part by the National Eye Institute and the Glaucoma Research Foundation, make discovery that may help glaucoma patients who have lost vision.

GRF Scientific Advisors on Collaborative Research

Members of our Scientific Advisory Board talk about the success of the Catalyst for a Cure collaborative research model.

Personal Story: Pat Rospenda

“This disease must be conquered. I am taking its cure as a personal challenge.” — Pat Rospenda

What is MIGS?

The goal of all glaucoma surgery is to lower eye pressure. MIGS has become a commonly used abbreviation in the glaucoma world. It stands for minimally invasive glaucoma surgery.

Personal Story: Tracy Hammond

“When it comes to research, I give to Glaucoma Research Foundation.” — Tracy Hammond

Future Focus: Stem Cell Treatment for Glaucoma

Stem cells are undifferentiated cells which have the potential to develop into many different types of specialized tissues.

Ocular Hypertension Treatment

There are millions of people in the United States who have increased pressure in their eyes (intraocular pressure) without glaucoma. Often this condition is referred to as ocular hypertension.

Dr. Yvonne Ou discusses Lifestyle Modifications and Glaucoma

A glaucoma specialist answers questions glaucoma patients have regarding lifestyle modifications including diet, exercise, yoga, and acupuncture.

Catalyst for a Cure: Glaucoma Biomarker to Be Tested

The Catalyst for a Cure (CFC) Biomarker Initiative brings together four research laboratories to find new and sensitive measures for glaucoma.

Personal Story: Jenny Eisenberger

At age 32, Jenny learned that she had glaucoma from a routine eye exam.

Global Collaborations and Improving Glaucoma Care

Alan L. Robin, MD delivered the Robert N. Shaffer Lecture at the American Academy of Ophthalmology Annual Meeting in October 2014, Chicago, IL.

Restoring Vision: Retinal Nerve Cell Regeneration

Researchers have made great progress in understanding the process of optic nerve degeneration and regeneration in glaucoma.

Stick with the Program to Preserve Your Vision

Because vision loss from glaucoma starts with your side vision, you may not notice any symptoms until the disease has progressed significantly.

Brand Names and Generic Medications

Many common glaucoma medications are known by both their associated brand names and by generic names.

Free Glaucoma Screening Resources

Early detection, through regular and complete eye exams, is the key to protecting your vision from damage caused by glaucoma.

Glaucoma and Pregnancy: Minimizing Risk

If you are considering becoming pregnant, but have concerns because of your glaucoma, take heart. You are not alone.

Art Takahara Personal Story

“My message to those who have family members or friends who have learned that they have glaucoma is for them to try to understand for themselves what the disease is all about.”

The Eye Exam Demystified

While you may not look forward to your annual health exams, including eye exams, it’s important for maintaining your well-being.